Patent details

Basic Information

Publication number:

EP2699231

PCT Application Number:

IB2012051946

Type:

European Patent Granted for LU

Legal Status:

Lapsed

Application number:

EP127232411

PCT Publication Number:

WO2012143868

First applicant's nationality:

Translation Language:

EPO Publication Language:

English

English Title of Invention:

SUSPENSION TYPE TOPICAL FORMULATIONS COMPRISING CYCLIC DEPSIPEPTIDE

French Title of Invention:

FORMULATIONS TOPIQUES DE TYPE SUSPENSION COMPRENANT UN DEPSIPEPTIDE CYCLIQUE

German Title of Invention:

TOPISCHE SUSPENSIONSFORMULIERUNGEN MIT CYCLISCHEN DEPSIPEPTIDEN

SPC Number:

Dates

Filing date:

18/04/2012

Grant date:

13/09/2017

EP Publication Date:

26/02/2014

PCT Publication Date:

26/10/2012

Claims Translation Received Date:

Translations Received Date (B1 EP Publication):

Translations Received Date (B2 EP Publication):

Translations Received Date (B3 EP Publication):

Publication date:

13/09/2017

EP B1 Publication Date:

13/09/2017

EP B2 Publication Date:

EP B3 Publication Date:

Lapsed date:

18/04/2018

Expiration date:

18/04/2032

Renunciation date:

Revocation date:

Annulment date:

Owner

From:

13/09/2017

 

 

Name:

Novartis AG

Address:

Lichtstrasse 35, 4056 Basel, Switzerland (CH)

Inventor

Name:

HAUG, Claire

Address:

Switzerland (CH)

Priority

Priority Number:

201161477297 P

Priority Date:

20/04/2011

Priority Country:

United States (US)

Classification

IPC classification:

A61K 9/00; A61K 9/06; A61K 38/15; A61K 47/06; A61P 17/00; A61K 47/14;

Publication

European Patent Bulletin

Issue number:

201737

Publication date:

13/09/2017

Description:

Grant (B1)

Annual Fees

Annual Fee Due Date:

Annual Fee Number:

Expected Payer:

Last Annual Fee Payment Date:

Last Annual Fee Paid Number:

Payer:

Filing date	Document type	Number of pages
30/08/2018	Outgoing Correspondence	1